For adults with obesity but without diabetes, GLP-1 RA use is associated with a significantly lower...
GLP-1 Receptor Agonist Use Linked to Lower Incidence of Obesity-Associated Cancers
For adults with obesity but without diabetes, GLP-1 RA use is associated with a significantly lower short-term incidence of OACs.
Author: Endocrinology Advisor
Read Original Article